85 Results

People

  1. Dogan
    Dogan
  2. Landgren
    Landgren
  3. Lesokhin
    Lesokhin
  4. Hultcrantz
    Hultcrantz
  5. Landau
    Landau
  6. Giralt
    Giralt
  7. Intlekofer
    Intlekofer
  8. Hassoun
    Hassoun
  9. Korde
    Korde
  10. Mailankody
    Mailankody

Groups

  1. Center for Hematologic Malignancies (85)
  2. Department of Medicine (85)
  3. Hematologic Malignancies Research (85)
  4. Hematologic Malignancies, Division of (84)
  5. Myeloma (54)
  6. Survivorship Research (44)
  7. Sloan Kettering Institute Postdocs (43)
  8. Epidemiology and Biostatistics (42)
  9. GSK Faculty (42)
  10. Biostatistics Service (34)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Ahmet Dogan"
Formats
  1. Meeting Abstract (50)
  2. Journal Article (33)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (85)
  2. Department of Medicine (85)
  3. Hematologic Malignancies Research (85)
  4. Hematologic Malignancies, Division of (84)
  5. Myeloma (54)
  6. Survivorship Research (44)

More Groups

People
  1. Ahmet Dogan (85)
  2. Carl Landgren (34)
  3. Alexander Lesokhin (33)
  4. Malin Hultcrantz (30)
  5. Mikhail Roshal (29)
  6. Heather Landau (27)

More People

Years
  1. 2023 (12)
  2. 2022 (8)
  3. 2021 (11)
  4. 2020 (13)
  5. 2019 (7)
  6. 2018 (8)

More Years

Publications
  1. Blood (41)
  2. Blood Advances (5)
  3. Modern Pathology (5)
  4. Blood Cancer Journal (3)
  5. Clinical Lymphoma, Myeloma and Leukemia (3)
  6. Journal of Molecular Diagnostics (3)

More Publications

Publishers
  1. American Society of Hematology (46)
  2. Nature Publishing Group (8)
  3. Nature Research (6)
  4. Elsevier Inc. (5)
  5. American Association for Cancer Research (4)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (85)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Journal Article

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revealing novel mechanisms underlying inactivation of tumor suppressor genes on duplicated chromosomes in multiple myeloma
    Meeting Abstract

    Cirrincione, A.; Kaddoura, M.; Poos, A. M.; Ziccheddu, B.; Maclachlan, K. H.; Chojnacka, M.; Diamond, B.; Blaney, P.; Gagler, D.; Zhang, Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Blaney, P.; Ziccheddu, B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Tracking the earliest genomic events in multiple myeloma life-history
    Meeting Abstract

    Cirrincione, A.; Poos, A.; Kaddoura, M.; Ziccheddu, B.; Maclachlan, K.; Chojnacka, M.; Diamond, B.; Papadimitriou, M.; Blaney, P.; Gagler, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
    Journal Article

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Moskowitz, A. J.; Stuver, R. N.; Maccaro, C. R.; Galasso, N.; Chang, T.; Khan, N.; Aypar, U.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save